XETRA - Delayed Quote EUR

aap Implantate AG (AAQ1.DE)

1.2600
+0.0300
+(2.44%)
At close: May 16 at 5:36:08 PM GMT+2
Loading Chart for AAQ1.DE
  • Previous Close 1.2300
  • Open 1.2600
  • Bid --
  • Ask --
  • Day's Range 1.2600 - 1.2600
  • 52 Week Range 1.0600 - 2.9800
  • Volume 2,000
  • Avg. Volume 1,476
  • Market Cap (intraday) 17.523M
  • Beta (5Y Monthly) 0.06
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4900
  • Earnings Date Jun 20, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, wrist, and shoulder; and straight plates and cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

www.aap.de

87

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AAQ1.DE

View More

Performance Overview: AAQ1.DE

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

AAQ1.DE
5.26%
DAX P (^GDAXI)
19.38%

1-Year Return

AAQ1.DE
5.97%
DAX P (^GDAXI)
26.84%

3-Year Return

AAQ1.DE
57.72%
DAX P (^GDAXI)
70.20%

5-Year Return

AAQ1.DE
72.10%
DAX P (^GDAXI)
127.11%

Compare To: AAQ1.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AAQ1.DE

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    17.52M

  • Enterprise Value

    21.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.91

  • Price/Book (mrq)

    1.42

  • Enterprise Value/Revenue

    1.84

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.32%

  • Return on Assets (ttm)

    -11.28%

  • Return on Equity (ttm)

    -17.22%

  • Revenue (ttm)

    11.96M

  • Net Income Avi to Common (ttm)

    -2.31M

  • Diluted EPS (ttm)

    -0.4900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    780k

  • Total Debt/Equity (mrq)

    27.02%

  • Levered Free Cash Flow (ttm)

    -1.8M

Research Analysis: AAQ1.DE

View More

People Also Watch